Dr. Durand is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5445 Matthew Ct
Sarasota, FL 34231Phone+1 941-554-4064Fax+1 941-554-4064
Education & Training
- Stony Brook Medicine/University HospitalFellowship, Cytopathology, 1995 - 1996
- Temple University HospitalResidency, Pathology-Anatomic and Clinical, 1989 - 1990
- University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1988 - 1989
- Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 1987 - 1988
- Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 1985 - 1987
- University of Pennsylvania Health SystemInternship, Pathology-Anatomic and Clinical, 1983 - 1985
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1983
Certifications & Licensure
- FL State Medical License 2008 - 2026
- NY State Medical License 1995 - 2017
- OK State Medical License 1992 - 1995
- VT State Medical License 1990 - 1992
- PA State Medical License 1988 - 1990
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- Clinical Investigator Award NIH, 1985-1987
Publications & Presentations
PubMed
- 746 citationsIdentification of a putative regulator of early T cell activation genesJeng-Pyng Shaw, Paul J. Utz, D B Durand, J. J. Toole, Elizabeth A. Emmel
Science. 1988-07-08 - 530 citationsCyclosporin A specifically inhibits function of nuclear proteins involved in T cell activationElizabeth A. Emmel, Cornelis L. Verweij, D B Durand, Kay M. Higgins, Elizabeth Lacy
Science. 1989-12-22 - 131 citationsA 275 BASEPAIR FRAGMENT AT THE 5' END OF THE INTERLEUKIN 2 GENE ENHANCES EXPRESSION FROM A HETEROLOGOUS PROMOTER IN RESPONSE TO SIGNALS FROM THE T CELL ANTIGEN RECEPTORD B Durand, M R Bush, John G. Morgan, Arthur Weiss, Gerald R. Crabtree
The Journal of Experimental Medicine. 1987-02-01
Journal Articles
- Phage display selection of peptides that affect prostate carcinoma cells attachment and invasionVictor Romanov, David Durand, Valerie Petrenko, The Prostate, 6/2001
- Characterization of antigen receptor response elements within the interleukin-2 enhancer (Discovery of NF-AT)Durand DB, Shaw J-P, Bush MR, Replogle RE, Belagaje R, and Crabtree GR, Molecular and Cellular Biology, 1988
- Promoter Region of Interleukin-2 Gene Undergoes Chromatin Structure Changes and Confers Inducibility on Chloramphenicol Acetyltransferase Gene during Activation of T C...Ulrich Siebenlist, David B. Durand, Peter Bressler, Nikki J. Holbrook, Carol A. Norris, Malek Kamoun, Jeffrey A. Kant, and Gerald R. Crabtree .., Molecular and Cellular Biology, 9/1986
- Join now to see all
External Links
- Three Step Healing™http://ThreeStepHealing.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: